ATE371441T1 - Verfahren zur herstellung einer pharmazeutischen zubereitung mit 5-aminosalicylsäure zur verwendung bei der behandlung von colitis ulcerosa und morbus crohn - Google Patents
Verfahren zur herstellung einer pharmazeutischen zubereitung mit 5-aminosalicylsäure zur verwendung bei der behandlung von colitis ulcerosa und morbus crohnInfo
- Publication number
- ATE371441T1 ATE371441T1 AT01978213T AT01978213T ATE371441T1 AT E371441 T1 ATE371441 T1 AT E371441T1 AT 01978213 T AT01978213 T AT 01978213T AT 01978213 T AT01978213 T AT 01978213T AT E371441 T1 ATE371441 T1 AT E371441T1
- Authority
- AT
- Austria
- Prior art keywords
- preparing
- crohn
- disease
- treatment
- ulcerative colitis
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- KBOPZPXVLCULAV-UHFFFAOYSA-N mesalamine Chemical compound NC1=CC=C(O)C(C(O)=O)=C1 KBOPZPXVLCULAV-UHFFFAOYSA-N 0.000 title abstract 3
- 229960004963 mesalazine Drugs 0.000 title abstract 3
- 206010009900 Colitis ulcerative Diseases 0.000 title abstract 2
- 208000011231 Crohn disease Diseases 0.000 title abstract 2
- 201000006704 Ulcerative Colitis Diseases 0.000 title abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 238000005469 granulation Methods 0.000 abstract 1
- 230000003179 granulation Effects 0.000 abstract 1
- 239000008203 oral pharmaceutical composition Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/DK2001/000677 WO2003032952A1 (en) | 2001-10-15 | 2001-10-15 | Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn's disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE371441T1 true ATE371441T1 (de) | 2007-09-15 |
Family
ID=8149447
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01978213T ATE371441T1 (de) | 2001-10-15 | 2001-10-15 | Verfahren zur herstellung einer pharmazeutischen zubereitung mit 5-aminosalicylsäure zur verwendung bei der behandlung von colitis ulcerosa und morbus crohn |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1441700B1 (de) |
| JP (1) | JP4726414B2 (de) |
| KR (1) | KR100859358B1 (de) |
| CN (1) | CN100506234C (de) |
| AT (1) | ATE371441T1 (de) |
| CA (1) | CA2462905C (de) |
| DE (1) | DE60130270T2 (de) |
| DK (1) | DK1441700T3 (de) |
| ES (1) | ES2288999T3 (de) |
| IL (2) | IL161193A0 (de) |
| MX (1) | MXPA04003506A (de) |
| NO (1) | NO335042B1 (de) |
| PT (1) | PT1441700E (de) |
| WO (1) | WO2003032952A1 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070059368A1 (en) * | 2005-05-31 | 2007-03-15 | Cherukuri S R | Modified release formulations of anti-irritability drugs |
| WO2004093883A2 (en) | 2003-04-23 | 2004-11-04 | Ferring B.V. | Sachet for a pharmaceutical composition |
| EP1470819A1 (de) * | 2003-04-23 | 2004-10-27 | Ferring B.V. | Sachet mit hohem Anteil an Mesalazin |
| EP1547601A1 (de) * | 2003-12-23 | 2005-06-29 | Ferring B.V. | Beschichtungsverfahren |
| ES2323536T3 (es) * | 2004-09-01 | 2009-07-20 | The Procter And Gamble Company | Composiciones que comprenden acido-5-amino-2-hidroxibenzoico yh un azucar reductor. |
| GB0909680D0 (en) | 2009-06-05 | 2009-07-22 | Euro Celtique Sa | Dosage form |
| EP2340812A1 (de) | 2009-12-18 | 2011-07-06 | Ferring International Center S.A. | Granulat für pharmazeutische Präparate sowie Verfahren und Vorrichtungen zu ihrer Herstellung |
| WO2012032185A1 (de) * | 2010-09-10 | 2012-03-15 | Pharmazell Gmbh | Verfahren zur herstellung kristalliner 5-aminosalicylsäure |
| EP2822542A1 (de) * | 2012-03-07 | 2015-01-14 | Santarus, Inc. | Gesteuerte freisetzung fester dosierungsformen von mesalamin |
| CN103622974B (zh) * | 2013-12-05 | 2016-04-20 | 武汉武药科技有限公司 | 一种含美沙拉嗪和n-乙酰半胱氨酸的复方栓剂及其制备方法 |
| EP3154523B1 (de) * | 2014-06-16 | 2018-11-21 | Valpharma International S.P.A. | Formulierung zur oralen verabreichung mit mesalazin |
| ITUA20162293A1 (it) * | 2016-04-05 | 2017-10-05 | Sofar Spa | Processo per formulazioni solide di mesalazina |
| JP2017189121A (ja) * | 2016-04-11 | 2017-10-19 | 国立大学法人旭川医科大学 | 抗ＴＮＦα抗体適応疾患の治療における抗ＴＮＦα抗体投与時反応の発症リスクを判定する方法、並びに該判定用オリゴヌクレオチドキット |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1981002671A1 (en) * | 1980-03-20 | 1981-10-01 | Ferring Farma Lab | Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration |
| JPH0334928A (ja) * | 1989-06-29 | 1991-02-14 | Teikoku Seiyaku Kk | 潰瘍性大腸炎およびクローン病治療用経口投与製剤 |
| UA67721C2 (en) * | 1995-12-21 | 2004-07-15 | Ferring Farma Lab | Modified release pharmaceutical composition and method for treatment of inflammatory bowel diseases |
| IT1303753B1 (it) * | 1998-11-13 | 2001-02-23 | Ct Lab Farm Srl | Composizioni farmaceutiche somministrabili per via orale contenentiun rivestimento gastroresistente a base di polimeri acrilici. |
| IT1318625B1 (it) * | 2000-07-14 | 2003-08-27 | Roberto Valducci | Formulazioni farmaceutiche solide orali a rilascio multifasicoph-dipendente. |
-
2001
- 2001-10-15 CN CNB018237096A patent/CN100506234C/zh not_active Expired - Lifetime
- 2001-10-15 JP JP2003535756A patent/JP4726414B2/ja not_active Expired - Lifetime
- 2001-10-15 KR KR1020047005406A patent/KR100859358B1/ko not_active Expired - Lifetime
- 2001-10-15 DK DK01978213T patent/DK1441700T3/da active
- 2001-10-15 DE DE60130270T patent/DE60130270T2/de not_active Expired - Lifetime
- 2001-10-15 PT PT01978213T patent/PT1441700E/pt unknown
- 2001-10-15 MX MXPA04003506A patent/MXPA04003506A/es active IP Right Grant
- 2001-10-15 WO PCT/DK2001/000677 patent/WO2003032952A1/en not_active Ceased
- 2001-10-15 IL IL16119301A patent/IL161193A0/xx unknown
- 2001-10-15 EP EP01978213A patent/EP1441700B1/de not_active Expired - Lifetime
- 2001-10-15 CA CA2462905A patent/CA2462905C/en not_active Expired - Lifetime
- 2001-10-15 ES ES01978213T patent/ES2288999T3/es not_active Expired - Lifetime
- 2001-10-15 AT AT01978213T patent/ATE371441T1/de active
-
2004
- 2004-03-31 IL IL161193A patent/IL161193A/en not_active IP Right Cessation
- 2004-05-14 NO NO20042011A patent/NO335042B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2462905A1 (en) | 2003-04-24 |
| HK1068282A1 (en) | 2005-04-29 |
| DE60130270T2 (de) | 2008-05-29 |
| KR20040047906A (ko) | 2004-06-05 |
| NO335042B1 (no) | 2014-09-01 |
| CN100506234C (zh) | 2009-07-01 |
| ES2288999T3 (es) | 2008-02-01 |
| IL161193A0 (en) | 2004-08-31 |
| EP1441700B1 (de) | 2007-08-29 |
| CN1558752A (zh) | 2004-12-29 |
| IL161193A (en) | 2010-05-31 |
| PT1441700E (pt) | 2007-10-29 |
| EP1441700A1 (de) | 2004-08-04 |
| MXPA04003506A (es) | 2004-07-23 |
| JP2005509619A (ja) | 2005-04-14 |
| JP4726414B2 (ja) | 2011-07-20 |
| WO2003032952A1 (en) | 2003-04-24 |
| DK1441700T3 (da) | 2007-10-08 |
| KR100859358B1 (ko) | 2008-09-22 |
| CA2462905C (en) | 2011-04-12 |
| DE60130270D1 (de) | 2007-10-11 |
| NO20042011L (no) | 2004-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60130270D1 (de) | Verfahren zur herstellung einer pharmazeutischen zubereitung mit 5-aminosalicylsäure zur verwendung bei der behandlung von colitis ulcerosa und morbus crohn | |
| DE122005000001I2 (de) | Zweiwertige Metallsalze von 2-N, N-di(carboxymethyl)-amino-3-cyano-4-carboxymethyl-5-carboxy-thiophens{ure, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen | |
| ATE324909T1 (de) | Stabile medizinische zusammensetzungen zur oralen verabreichung unter verwendung von eisenoxiden | |
| DE68923819D1 (de) | Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen. | |
| DE60100625D1 (de) | Verwndung von verbindungen mit 5-ht1a aktivität zur behandlung von krankheiten der äusseren retina | |
| TR200200716T2 (tr) | Ketiyapin granülleri | |
| DE60042972D1 (de) | Trimetazidine enthaltendes Arzneimittel mit verzögerter Wirkstoffabgabe und Verfahren zur Herstellung | |
| ATE439833T1 (de) | Pharmazeutische zubereitung enthaltend ein catechin, ascorbinsäure, prolin und lysin zur behandlung von neoplastischen krankheiten | |
| DE69615400D1 (de) | 5-asa enthaltendes orales arzneimittel mit modifizierter freisetzung sowie verfahren zur behandlung von darmerkrankungen | |
| DE60035429D1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
| DE68917937D1 (de) | Verbindungen mit magensäureinhibitorwirkung und verfahren zur herstellung. | |
| ATE100095T1 (de) | 2,2-dimethylchromenderivate, verfahren zur herstellung und diese enthaltende pharmazeutische zusammenstellungen. | |
| MY137570A (en) | Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis crohn's disease | |
| HUP9802897A2 (hu) | Optikailag aktív piridil-4H-1,2,4-oxadiazin-származék, annak alkalmazása vaszkuláris betegségek kezelésére, valamint ilyen származékot hatóanyagként tartalmazó gyógyászati készítmény | |
| ATE458471T1 (de) | Formulierungen mit povidon-iod zur behandlung von wunden | |
| DE60230629D1 (de) | Verwendung von 2,5-dihydroxybenzolsulfonsäure-derivaten bei der herstellung eines medikaments zur verstärkung der wirkung anderer arzneimittel zur behandlung der erektilen dysfunktion | |
| ATE152350T1 (de) | Pharmazeutische zusammensetzungen die 5- difluormethoxy-2-(3,4-dimethoxy-2- pyridyl)methylsulfinyl>-1h-benzimidazol und ein anti-heliobactermittel enthalten zur behandlung von magen-darm krankheiten | |
| DE60113807D1 (de) | Stabilisierte pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung, mit einem antibiotikum und einem expektorans | |
| RU92001958A (ru) | Способ получения фибринной пасты | |
| DE60036758D1 (de) | Verfahren zur Herstellung von optisch aktiver 3,3,3-Trifluor-2-hydroxy-2-methylpropionsäure und deren Salze | |
| DE3872881D1 (de) | Arzneimittelzusammensetzung zur vorbeugung und behandlung bakterieller und viraler krankheiten. | |
| DE69903610D1 (de) | Verfahren zur Herstellung von 5,5'-bi-1H-Tetrazol-Salz | |
| ATE12649T1 (de) | Optisch aktives dipeptide, seine pharmazeutisch vertraeglichen salze, verfahren zur herstellung und diese enthaltende pharmazeutische praeparate. | |
| DE59003806D1 (de) | Zubereitung eines salzes von oxypurinol in oraler form zur behandlung von hyperuricämie. | |
| DE60114532D1 (de) | Verfahren zur Herstellung von optisch activem 1H-3-Aminopyrrolidin und Derivaten davon |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1441700 Country of ref document: EP |